Cardlytics, Inc. — Director's Dealing 2024

Nov 16, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2024-11-14

Reporting Person: DeSieno Alexis (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-14	Common Stock	M	43750	—	Acquired	141599	Direct
2024-11-15	Common Stock	S	25118	$3.43	Disposed	116481	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-14	Restricted Stock Units	$	M	43750	Disposed		Common Stock (43750)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.

F2: Shares were sold solely to satisfy withholding tax obligations that resulted from the delivery of shares of common stock for RSUs that vested on November 15, 2024. The Reporting Person did not sell shares for any other purpose.

F3: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.32 to $3.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3)

F4: The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% having vested or vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.